May 3, 2011

Market Insight – Clarity Needed Over ASEAN Regulators’ Position

Scrip World Pharmaceutical News

The variety and ever-changing nature of regulations governing patent and drug approvals across the Asian region, along with policies which often favor local generics, can pose a daunting challenge for multinational research-based pharmaceutical companies. This article takes a look at some of the major issues and how they can be addressed.

AUTHORS

RELATED INSIGHTS​